MERILEE RAINES
CIK 1023869 · Executive VP & CFO · last filed 2026-08-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$34.49M
Companies
7
Total Filings
68
Lifetime Open-Market Net
-$38.68M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WTS | Director | 21,670 | $377.12 | $8.17M | $0 | 17 | 2026-08-04 |
| OCUL | Director | 60,933 | $8.74 | $532.6K | $0 | 6 | 2026-06-12 |
| TMDX | Director | 6,981 | $80.21 | $559.9K | $0 | 7 | 2026-05-22 |
| BHE | Director | 24,489 | $82.37 | $2.02M | $0 | 3 | 2021-05-14 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 0 | — | — | $0 | 7 | 2019-07-18 |
| AFFYMETRIX INC (AFFX) Delisted | Director | 0 | — | — | $0 | 3 | 2016-04-01 |
| IDXX | Executive VP & CFO | 39,332 | $590.00 | $23.21M | -$38.68M | 25 | 2013-02-27 |
Recent Filings · Page 5 of 7
68 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-02-27 | IDXX | Exer (M) | +15,871 | $845.7K | EDGAR |
| 2013-02-19 | IDXX | Mixed | +906 | -$84.0K | EDGAR |
| 2013-02-05 | IDXX | Mixed | −63,200 | -$12.24M | EDGAR |
| 2013-02-05 | IDXX | Sell (S) | −86,451 | -$8.25M | EDGAR |
| 2013-01-11 | IDXX | Mixed | — | -$575.2K | EDGAR |
| 2012-12-14 | IDXX | Mixed | — | -$563.0K | EDGAR |
| 2012-11-15 | IDXX | Mixed | — | -$522.0K | EDGAR |
| 2012-11-07 | IDXX | Sell (S) | −25,000 | -$2.35M | EDGAR |
| 2012-10-11 | IDXX | Mixed | — | -$566.8K | EDGAR |
| 2012-09-14 | IDXX | Mixed | — | -$583.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.